BD
Bratton Douglas K cut its AQST stake below 5%
Bratton Douglas K reported owning 0.6% of Aquestive Therapeutics, Inc. (AQST) (691,873 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 7, 2026
- Source
- Schedule 13G